Hypersomnia due to a medication or substance (Q41262): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Hipersonia devido ao uso de medicamento ou substância é caracterizada por sono noturno excessivo, sonolência diurna, ou cochilos excessivos que é atribuído aos efeitos sedativos do medicamento, álcool, ou outras substâncias psicoativas, incluindo as síndromes de abstinência (p.ex. de estimulantes) e é grave o suficiente para constituir um foco independente de atenção clínica._x000D_ _x000D_ Nota: Um diagnóstico definitivo requer o uso de polissonografia e do teste das múltiplas latências do sono (TMLS) para excluir outros transtornos de hipersonolência ou outros transtornos do sono (e.g. apneia obstrutiva do sono) que podem explicar melhor a sonolência.
description / endescription / en
 
Hypersomnia due to a medication or substance is characterised by excessive nocturnal sleep, daytime sleepiness, or excessive napping that is attributable to the sedating effects of medications, alcohol, or other psychoactive substances, including withdrawal syndromes (e.g., from stimulants) and is sufficiently severe to constitute an independent focus of clinical attention. Note: A definitive diagnosis requires use of polysomnography and multiple sleep latency test (MSLT) to rule out other hypersomnolence disorders or other sleep disorders (e.g. obstructive sleep apnea) which might better explain the sleepiness.

Revision as of 07:21, 13 August 2026

Hypersomnia due to a medication or substance is characterised by excessive nocturnal sleep, daytime sleepiness, or excessive napping that is attributable to the sedating effects of medications, alcohol, or other psychoactive substances, including withdrawal syndromes (e.g., from stimulants) and is sufficiently severe to constitute an independent focus of clinical attention. Note: A definitive diagnosis requires use of polysomnography and multiple sleep latency test (MSLT) to rule out other hypersomnolence disorders or other sleep disorders (e.g. obstructive sleep apnea) which might better explain the sleepiness.
Language Label Description Also known as
default for all languages
7A24
    English
    Hypersomnia due to a medication or substance
    Hypersomnia due to a medication or substance is characterised by excessive nocturnal sleep, daytime sleepiness, or excessive napping that is attributable to the sedating effects of medications, alcohol, or other psychoactive substances, including withdrawal syndromes (e.g., from stimulants) and is sufficiently severe to constitute an independent focus of clinical attention. Note: A definitive diagnosis requires use of polysomnography and multiple sleep latency test (MSLT) to rule out other hypersomnolence disorders or other sleep disorders (e.g. obstructive sleep apnea) which might better explain the sleepiness.

      Statements